EUVIMEDEUVIMED entdecken
Multizentrische Studie

Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis

Fang Chen iD, Li Zhuang, Wenzhi Guo, Lei Xia, Jianjun Zhang, Qiang Xia, Ting Wang, Yongbing Qian iD

Transplant Infectious Disease · 2025

DOI: 10.1111/tid.70160 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Fang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, Liver Transplantation, Antifungal Agents, Acute-On-Chronic Liver Failure. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Medical Innovation Research of Shanghai Science and Technology Innovation Action, Shanghai Jiao Tong University Integrated Innovation Fund, Shanghai Key Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with acute‐on‐chronic liver failure (ACLF) are susceptible to fungal infections. However, pretransplant invasive pulmonary Aspergillosis (IPA) is generally considered a relative contraindication for liver transplantation (LT).

Methods

We conducted a multi‐center retrospective study involving ACLF adult patients with pretransplant IPA who underwent LT at four hospitals between January 2021, and June 2024. For comparative analysis, we included a control group of ACLF patients without preoperative Aspergillus infection during the same period, from the Renji Hospital cohort with matching approach. Posttransplant outcomes were then evaluated and compared between the two groups (ACLF patients with IPA vs. those without IPA).

Results

A total of 21 patients who had IPA before LT was identified. The mean age was 46.7 ± 9.2 years. The mean MELD score of these patients was 28.6. Most (71.4%, 15/21) patients received antifungal therapy immediately after the diagnosis of IPA. Twelve patients received voriconazole, one received isavuconazole, one received posaconazole, one received amphotericin B plus caspofungin and isavuconazole, the remaining six patients did not receive any antifungal drugs before LT. The median duration of antifungal therapy was 9 days (range: 0.5–34.5 days) before transplantation, overall median duration of antifungal treatment was 58 days (range: 22–83). The 3‐month (38.1%, 8/21) and 12‐month mortality (42.9%, 9/21) were significantly higher than patients without pretransplant IPA ( p = 0.049 and p = 0.026, respectively).

Conclusions

The survival of LT for ACLF patients with pretransplant IPA was suboptimal, although they had received appropriate antifungal treatment within the peri‐transplantation period. Multidisciplinary discussions before transplantation are necessary on case‐by‐case. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisLiver TransplantationAntifungal AgentsAcute-On-Chronic Liver FailureHumansMaleMiddle AgedRetrospective StudiesFemaleAdultCritical IllnessTreatment Outcome

Stichwörter der Autor:innen

acute‐on‐chronic liver failureinvasive pulmonary Aspergillosisliver transplantationmultidisciplinary discussionoutcome

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Liver Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Pharmacy, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Critical Care Medicine, School of Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Fang Chen, Yongbing Qian

Förderung

  • Medical Innovation Research of Shanghai Science and Technology Innovation Action
  • Shanghai Jiao Tong University Integrated Innovation Fund
  • Shanghai Key Research Center

Zitieren

APA

Chen, F., Zhuang, L., Guo, W., Xia, L., Zhang, J., Xia, Q., Wang, T., & Qian, Y. (2025). Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis. Transplant Infectious Disease. https://doi.org/10.1111/tid.70160

Vancouver

Chen F, Zhuang L, Guo W, Xia L, Zhang J, Xia Q, et al. Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis. Transplant Infectious Disease. 2025. doi:10.1111/tid.70160

BibTeX
@article{Chen2025,
  author = {Chen, Fang and Zhuang, Li and Guo, Wenzhi and Xia, Lei and Zhang, Jianjun and Xia, Qiang and Wang, Ting and Qian, Yongbing},
  title = {Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis},
  journal = {Transplant Infectious Disease},
  year = {2025},
  doi = {10.1111/tid.70160}
}
Kostenlos starten →